Molecular Partners (MOLN) said Tuesday it plans to reduce its workforce by up to 24%, or up to 40 positions.
The company said it expects its cash runway to extend into 2028, beyond its previous outlook of 2027, as a result of the job cuts.
Molecular Partners expects the full implementation of the changes to be enacted by the end of this year and the cost reduction to become fully effective in early 2026.